Mercy Kibe is an Ophthalmology physician. OpenAlex indexes 7 publications with 259 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
395 W 12th Ave
Third Floor
Columbus, OH 432101267
Telephone
614-293-3989Provider last certified this registry record 26 Apr 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Alcon Vision LLCProgram year20212 payments
- Allergan, Inc.Program year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
94.8%Antineovascularisation agents93.3%Faricimab-svoa100%Part B, office-administered≥16 patientsCarbonic Anhydrase Inhibitor0.7%Dorzolamide-Timolol68%Dorzolamide Hcl32%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
4.5%Vascular Endothelial Growth Factor Inhibitor4.5%Aflibercept100%Part B, office-administered≥27 patientsMusculoskeletal
0.6%Cyclooxygenase Inhibitor0.6%Ketorolac Tromethamine100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
American Journal of Ophthalmology Case Reports
2022 - Acute Posterior Vitreous Detachment – Evaluating modalities of detection and associated clinical findings
Investigative Ophthalmology & Visual Science
2020 - Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma
The Ophthalmology - Open Journal
2019 - PKC-delta as a Survival Regulator in Uveal Melanoma
Investigative Ophthalmology & Visual Science
2017 - Modulation of Cytoskeletal Adaptor Proteins in Uveal Melanoma to Control Metastasis
Investigative Ophthalmology & Visual Science
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”